Settore Shield Therapeutics plc

Azioni

STX

GB00BYV81293

Prodotti farmaceutici

Mercato chiuso - London S.E. 17:35:08 16/12/2025 Variaz. 5gg Var. 1 gen.
11,20 GBX +4,67% Grafico intraday di Shield Therapeutics plc +9,27% +314,81%
Principali concorrenti
Variaz. Variaz. 5g. Variazione 1 mese Variazione 3 mesi Variaz. 1 gen. Variaz. 1 anno Variaz. 3 anni Variaz. 5 anni Variaz. 10 anni Capi.($)
+4,67%+9,27%+65,93%+38,27%+314,81%+318,69%+65,93%-81,64% - 152 Mln
-0,83%+7,77%+7,62%+29,79%+4,78%+2,96%+3,21%+53,39%+33,36% 77,22 Mrd
-2,25%-4,63%-4,00%-13,85%-38,48%-37,89%-39,94%-39,89%+67,32% 57,5 Mrd
+1,02%+79,00%+79,00%+79,00%+79,00%+79,00%+79,00%+79,00% - 55,88 Mrd
-0,25%-1,94%+4,67%+16,48%+23,57%+28,03%+224,81%+171,49%+190,13% 53,2 Mrd
-2,41%-2,47%+2,36%+19,36%+12,15%+13,96%-39,82%-30,90%-42,70% 25,78 Mrd
-1,63%+1,97%-6,84%+15,65%+40,48%+39,01%+18,29%+12,52%-17,62% 19,37 Mrd
+0,25%-2,81%-10,63%-15,91%+121,72%+124,17%+158,85%+18,55% - 18 Mrd
-2,87%-7,33%-23,56%-14,10%+36,83%+36,39%+1.020,37%+328,74%+8.096,77% 15,88 Mrd
+1,58%+5,61%+14,01%+47,00%+175,84%+173,15%+717,39%+22,99% - 14,36 Mrd
-0,04%-.--%-.--%-.--%+57,89%+54,94%+158,32%+385,89%+135,19% 14,02 Mrd
-2,16%-2,10%-6,82%+13,54%-0,13%0,00%+44,29%+87,46%+140,33% 12,04 Mrd
-0,10%+5,84%+20,67%+20,33%-28,11%-28,56%-84,54%-78,19% - 11,69 Mrd
+0,15%+0,94%+1,65%+73,67%+147,49%+115,54%+290,72%+142,16% - 10,83 Mrd
-0,67%-3,67%-5,41%-4,02%-21,24%-21,01%-52,34%-42,01%-49,10% 10,01 Mrd
-8,43%-3,73%+5,26%+31,19%+210,16%+206,02%+909,77%+822,62%+535,17% 8,83 Mrd
+0,08%-7,89%-22,42%-17,64%+322,37%+320,98%+220,60%+236,13%+145,51% 8,42 Mrd
-0,63%-3,76%-16,14%-21,36%-34,67%-38,46%-51,97%-35,56% - 8,32 Mrd
-0,55%+0,75%+1,36%-10,92%+18,11%+11,25%+3,94%-56,10%-48,30% 7,76 Mrd
+0,43%+1,14%+5,14%+28,72%+73,58%+63,77%+87,33%+82,65%+1.673,15% 7,37 Mrd
Media -0,73%-0,41%+5,59%+15,76%+75,81%+73,10%+186,71%+103,97%+835,32% 21,83 Mrd
Media ponderata per Capi. -0,85%+0,92%+10,28%+20,62%+39,17%+38,15%+131,81%+83,56%+519,00%
Biofarmaci
  1. Mercati
  2. Azioni
  3. Azione STX
  4. Settore Shield Therapeutics plc